

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.07404126 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.07404126 |
| 3 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 6.61668505 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.57061395 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.57061395 |
| 6 | axonemal dynein complex assembly (GO:0070286) | 6.38037121 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.28311301 |
| 8 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.28261957 |
| 9 | cilium movement (GO:0003341) | 6.08566413 |
| 10 | epithelial cilium movement (GO:0003351) | 5.98471332 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.85377520 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.63897276 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.63897276 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.63897276 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.60735974 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.42853278 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.37104904 |
| 18 | kynurenine metabolic process (GO:0070189) | 5.35154233 |
| 19 | urea cycle (GO:0000050) | 5.31158113 |
| 20 | urea metabolic process (GO:0019627) | 5.31158113 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.22625392 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.17195434 |
| 23 | glyoxylate metabolic process (GO:0046487) | 5.10152199 |
| 24 | cysteine metabolic process (GO:0006534) | 5.09737953 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02061087 |
| 26 | sensory perception of smell (GO:0007608) | 4.98914284 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.97291484 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.95840475 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.95508153 |
| 30 | protein carboxylation (GO:0018214) | 4.95508153 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 4.92857349 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.87757240 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.85104624 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.83893295 |
| 35 | bile acid metabolic process (GO:0008206) | 4.80021231 |
| 36 | regulation of complement activation (GO:0030449) | 4.60932767 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.59631634 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.59626835 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54404669 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.54404669 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.54404669 |
| 42 | phospholipid efflux (GO:0033700) | 4.54051800 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.51269216 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.47586181 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.46698698 |
| 46 | axoneme assembly (GO:0035082) | 4.46025861 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.44209101 |
| 48 | imidazole-containing compound metabolic process (GO:0052803) | 4.39196841 |
| 49 | drug metabolic process (GO:0017144) | 4.33736831 |
| 50 | alkaloid metabolic process (GO:0009820) | 4.32261938 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.29188443 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.28494313 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.28494313 |
| 54 | cholesterol efflux (GO:0033344) | 4.25185184 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.20199104 |
| 56 | omega-hydroxylase P450 pathway (GO:0097267) | 4.18135954 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.17861390 |
| 58 | regulation of cilium movement (GO:0003352) | 4.15316453 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.13325717 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.13325717 |
| 61 | cellular glucuronidation (GO:0052695) | 4.12663240 |
| 62 | drug catabolic process (GO:0042737) | 4.10060591 |
| 63 | lysine metabolic process (GO:0006553) | 4.09356252 |
| 64 | lysine catabolic process (GO:0006554) | 4.09356252 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.01361136 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 3.99042816 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 3.92494668 |
| 68 | ethanol oxidation (GO:0006069) | 3.91865568 |
| 69 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.90889587 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 3.88451020 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.86432511 |
| 72 | fibrinolysis (GO:0042730) | 3.85926725 |
| 73 | coenzyme catabolic process (GO:0009109) | 3.85525013 |
| 74 | cellular ketone body metabolic process (GO:0046950) | 3.83975781 |
| 75 | negative regulation of lipase activity (GO:0060192) | 3.83525215 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 3.80572046 |
| 77 | amine catabolic process (GO:0009310) | 3.80572046 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 3.78368592 |
| 79 | glutamate metabolic process (GO:0006536) | 3.77768813 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 3.74692463 |
| 81 | motile cilium assembly (GO:0044458) | 3.69579744 |
| 82 | phenylpropanoid metabolic process (GO:0009698) | 3.67167185 |
| 83 | regulation of guanylate cyclase activity (GO:0031282) | 3.64451460 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.63817684 |
| 85 | glycine metabolic process (GO:0006544) | 3.61863907 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.60360593 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.60360593 |
| 88 | plasma lipoprotein particle organization (GO:0071827) | 3.59092419 |
| 89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58833412 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58833412 |
| 91 | flavonoid metabolic process (GO:0009812) | 3.56940938 |
| 92 | serine family amino acid metabolic process (GO:0009069) | 3.56178538 |
| 93 | regulation of bile acid biosynthetic process (GO:0070857) | 3.54279048 |
| 94 | phospholipid homeostasis (GO:0055091) | 3.51883958 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.51148973 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.50460353 |
| 97 | heme transport (GO:0015886) | 3.49460859 |
| 98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49096983 |
| 99 | negative regulation of protein activation cascade (GO:2000258) | 3.46371863 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.44863271 |
| 101 | ethanol metabolic process (GO:0006067) | 3.44296186 |
| 102 | arginine metabolic process (GO:0006525) | 3.43810570 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.43491438 |
| 104 | organic acid catabolic process (GO:0016054) | 3.43491438 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.43355801 |
| 106 | cytolysis (GO:0019835) | 3.42850519 |
| 107 | exogenous drug catabolic process (GO:0042738) | 3.42825144 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.40524533 |
| 109 | complement activation (GO:0006956) | 3.40375473 |
| 110 | opsonization (GO:0008228) | 3.40284109 |
| 111 | drug transmembrane transport (GO:0006855) | 3.40126961 |
| 112 | cofactor catabolic process (GO:0051187) | 3.39691068 |
| 113 | protein activation cascade (GO:0072376) | 3.39562004 |
| 114 | sterol homeostasis (GO:0055092) | 3.38342274 |
| 115 | intraciliary transport (GO:0042073) | 3.38047680 |
| 116 | epoxygenase P450 pathway (GO:0019373) | 3.37578204 |
| 117 | angiotensin maturation (GO:0002003) | 3.36534709 |
| 118 | cilium organization (GO:0044782) | 3.30081878 |
| 119 | protein localization to cilium (GO:0061512) | 3.27662828 |
| 120 | response to nitrosative stress (GO:0051409) | 3.26053274 |
| 121 | cilium assembly (GO:0042384) | 3.22618967 |
| 122 | photoreceptor cell maintenance (GO:0045494) | 3.16014082 |
| 123 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.15069952 |
| 124 | cilium morphogenesis (GO:0060271) | 3.12388598 |
| 125 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.09562158 |
| 126 | oxidative demethylation (GO:0070989) | 3.09206396 |
| 127 | primary alcohol catabolic process (GO:0034310) | 3.08247175 |
| 128 | L-fucose catabolic process (GO:0042355) | 3.06161641 |
| 129 | fucose catabolic process (GO:0019317) | 3.06161641 |
| 130 | L-fucose metabolic process (GO:0042354) | 3.06161641 |
| 131 | auditory receptor cell differentiation (GO:0042491) | 3.05539150 |
| 132 | xenobiotic catabolic process (GO:0042178) | 3.03750504 |
| 133 | drug transport (GO:0015893) | 3.03335236 |
| 134 | iron coordination entity transport (GO:1901678) | 2.94156517 |
| 135 | negative regulation of humoral immune response (GO:0002921) | 2.87496558 |
| 136 | negative regulation of complement activation (GO:0045916) | 2.86003019 |
| 137 | nucleobase catabolic process (GO:0046113) | 2.83459175 |
| 138 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.82561747 |
| 139 | vitamin transmembrane transport (GO:0035461) | 2.80799147 |
| 140 | transepithelial transport (GO:0070633) | 2.80698563 |
| 141 | organic cation transport (GO:0015695) | 2.80059131 |
| 142 | hormone catabolic process (GO:0042447) | 2.75565889 |
| 143 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.71983799 |
| 144 | vitamin transport (GO:0051180) | 2.68113162 |
| 145 | C4-dicarboxylate transport (GO:0015740) | 2.67905351 |
| 146 | regulation of lipoprotein metabolic process (GO:0050746) | 2.66334620 |
| 147 | regulation of protein glycosylation (GO:0060049) | 2.66062957 |
| 148 | xenobiotic metabolic process (GO:0006805) | 2.64852237 |
| 149 | ketone body metabolic process (GO:1902224) | 2.63825316 |
| 150 | arginine catabolic process (GO:0006527) | 2.63220881 |
| 151 | regulation of microtubule-based movement (GO:0060632) | 2.62668514 |
| 152 | primary alcohol metabolic process (GO:0034308) | 2.62457150 |
| 153 | phenol-containing compound catabolic process (GO:0019336) | 2.62019954 |
| 154 | lipoprotein transport (GO:0042953) | 2.61765986 |
| 155 | excretion (GO:0007588) | 2.60655887 |
| 156 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.58011897 |
| 157 | retinal cone cell development (GO:0046549) | 2.56226239 |
| 158 | one-carbon compound transport (GO:0019755) | 2.55592494 |
| 159 | intestinal absorption (GO:0050892) | 2.55478145 |
| 160 | vitamin biosynthetic process (GO:0009110) | 2.53356512 |
| 161 | gamma-aminobutyric acid transport (GO:0015812) | 2.52322993 |
| 162 | sodium ion homeostasis (GO:0055078) | 2.51501681 |
| 163 | positive regulation of fatty acid transport (GO:2000193) | 2.51209838 |
| 164 | behavioral response to nicotine (GO:0035095) | 2.48866620 |
| 165 | diterpenoid biosynthetic process (GO:0016102) | 2.48748544 |
| 166 | digestion (GO:0007586) | 2.48721455 |
| 167 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.48352723 |
| 168 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.48352723 |
| 169 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.48041074 |
| 170 | sulfation (GO:0051923) | 2.46923047 |
| 171 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.46474600 |
| 172 | thyroid hormone metabolic process (GO:0042403) | 2.45074508 |
| 173 | microtubule bundle formation (GO:0001578) | 2.43814617 |
| 174 | positive regulation of icosanoid secretion (GO:0032305) | 2.43349488 |
| 175 | regulation of cGMP biosynthetic process (GO:0030826) | 2.43322477 |
| 176 | parturition (GO:0007567) | 2.41414267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.84346587 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.25220542 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.18220541 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.10423693 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77972959 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.68246000 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.46412289 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.46196417 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.23239582 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.01248185 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.53104528 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.42766795 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32267389 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.32267244 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17132415 |
| 16 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.14102774 |
| 17 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.91400002 |
| 18 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91144029 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90956531 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.87799518 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83439829 |
| 22 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.81614420 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72128865 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68685530 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66733069 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.65984281 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64762289 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63893524 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.63805385 |
| 30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.62915678 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61088703 |
| 32 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.60735192 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56363214 |
| 34 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.56052012 |
| 35 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.54887606 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.54887606 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53277159 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51227003 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48874301 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48531557 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47412702 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45494783 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44536484 |
| 44 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40897248 |
| 45 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39434448 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38988815 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37695296 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35734027 |
| 49 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35605454 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.34019058 |
| 51 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.33338453 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32866035 |
| 53 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.30948246 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29324743 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27890376 |
| 56 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.26616732 |
| 57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26437066 |
| 58 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.26274097 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26037724 |
| 60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25634531 |
| 61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25194218 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24886203 |
| 63 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23740424 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23349619 |
| 65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.23142436 |
| 66 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.22435457 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20799618 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20678321 |
| 69 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19003583 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18048253 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17767887 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17026369 |
| 73 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16948835 |
| 74 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16948835 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15326948 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14927304 |
| 77 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14559640 |
| 78 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14559640 |
| 79 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14451411 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14399294 |
| 81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13813710 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11494253 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11194742 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08872980 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08527810 |
| 86 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08413077 |
| 87 | TBL1_22424771_ChIP-Seq_293T_Human | 1.07815191 |
| 88 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07617350 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07586191 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07269325 |
| 91 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06789910 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06479859 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06336180 |
| 94 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.04561649 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01991524 |
| 96 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99442387 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98904140 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98567941 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98395890 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97928334 |
| 101 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.97412045 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95886434 |
| 103 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.93199481 |
| 104 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89914555 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87612383 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87180494 |
| 107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84708594 |
| 108 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83968121 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81244812 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81242747 |
| 111 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.80714767 |
| 112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80503606 |
| 113 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79606580 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78230334 |
| 115 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78081310 |
| 116 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75826048 |
| 117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74692249 |
| 118 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74382354 |
| 119 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.73786762 |
| 120 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.73113328 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.72832202 |
| 122 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.72786468 |
| 123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71677140 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.71550167 |
| 125 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71084235 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.70350799 |
| 127 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.69384823 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68070084 |
| 129 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.67514028 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67348199 |
| 131 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.67320291 |
| 132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.65532605 |
| 133 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.65496511 |
| 134 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.65029912 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.64941045 |
| 136 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.64322600 |
| 137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64026499 |
| 138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.63330067 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62352592 |
| 140 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.62306954 |
| 141 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.62241900 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62146170 |
| 143 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.61318473 |
| 144 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.60982488 |
| 145 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.60555203 |
| 146 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.60547496 |
| 147 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.59642026 |
| 148 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.59568430 |
| 149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.59560908 |
| 150 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.58957635 |
| 151 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57868424 |
| 152 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57485641 |
| 153 | NCOR_22424771_ChIP-Seq_293T_Human | 0.57356013 |
| 154 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.57021240 |
| 155 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.56955099 |
| 156 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.55898043 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.54979997 |
| 158 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54679044 |
| 159 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54309128 |
| 160 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.53932485 |
| 161 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.53129626 |
| 162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52443319 |
| 163 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.52375716 |
| 164 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.52317896 |
| 165 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.52083828 |
| 166 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.52083828 |
| 167 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.51442402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.58617600 |
| 2 | MP0005360_urolithiasis | 7.04327394 |
| 3 | MP0005365_abnormal_bile_salt | 5.87843099 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.86238261 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04851596 |
| 6 | MP0001984_abnormal_olfaction | 4.68570688 |
| 7 | MP0003252_abnormal_bile_duct | 4.31067138 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 4.29101228 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.23592188 |
| 10 | MP0002653_abnormal_ependyma_morphology | 2.92320715 |
| 11 | MP0004043_abnormal_pH_regulation | 2.76527956 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.72734938 |
| 13 | MP0003195_calcinosis | 2.69689531 |
| 14 | MP0009840_abnormal_foam_cell | 2.65220331 |
| 15 | MP0005083_abnormal_biliary_tract | 2.47708612 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.29195635 |
| 17 | MP0005332_abnormal_amino_acid | 2.17742660 |
| 18 | MP0000609_abnormal_liver_physiology | 2.05172662 |
| 19 | MP0004885_abnormal_endolymph | 2.02753460 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.02459865 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.02352960 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.99005139 |
| 23 | MP0000383_abnormal_hair_follicle | 1.98303414 |
| 24 | MP0001485_abnormal_pinna_reflex | 1.97697397 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.96384926 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.90763489 |
| 27 | MP0005410_abnormal_fertilization | 1.87440455 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.86374022 |
| 29 | MP0005451_abnormal_body_composition | 1.73851930 |
| 30 | MP0003868_abnormal_feces_composition | 1.67742185 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.65073947 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.64723699 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.62147698 |
| 34 | MP0003283_abnormal_digestive_organ | 1.62009801 |
| 35 | MP0003136_yellow_coat_color | 1.60373514 |
| 36 | MP0010386_abnormal_urinary_bladder | 1.53925530 |
| 37 | MP0004147_increased_porphyrin_level | 1.48758669 |
| 38 | MP0001764_abnormal_homeostasis | 1.44506011 |
| 39 | MP0008872_abnormal_physiological_respon | 1.41010959 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.40996009 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39853141 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.37766099 |
| 43 | MP0009379_abnormal_foot_pigmentation | 1.34914417 |
| 44 | MP0009697_abnormal_copulation | 1.33845744 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.32087684 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.28640526 |
| 47 | MP0002254_reproductive_system_inflammat | 1.28587177 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.24926721 |
| 49 | MP0003011_delayed_dark_adaptation | 1.24917221 |
| 50 | MP0002928_abnormal_bile_duct | 1.24033400 |
| 51 | MP0005253_abnormal_eye_physiology | 1.19351240 |
| 52 | MP0001486_abnormal_startle_reflex | 1.17559838 |
| 53 | MP0006292_abnormal_olfactory_placode | 1.17330676 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 1.12559531 |
| 55 | MP0006054_spinal_hemorrhage | 1.10036939 |
| 56 | MP0002938_white_spotting | 1.09684731 |
| 57 | MP0000462_abnormal_digestive_system | 1.09661397 |
| 58 | MP0005647_abnormal_sex_gland | 1.08945849 |
| 59 | MP0000516_abnormal_urinary_system | 1.08543096 |
| 60 | MP0005367_renal/urinary_system_phenotyp | 1.08543096 |
| 61 | MP0001664_abnormal_digestion | 1.08523373 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.08470356 |
| 63 | MP0000026_abnormal_inner_ear | 1.07253794 |
| 64 | MP0004381_abnormal_hair_follicle | 1.02337823 |
| 65 | MP0005646_abnormal_pituitary_gland | 0.99413771 |
| 66 | MP0002876_abnormal_thyroid_physiology | 0.98725030 |
| 67 | MP0001440_abnormal_grooming_behavior | 0.98512711 |
| 68 | MP0004270_analgesia | 0.96340584 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 0.95757568 |
| 70 | MP0009764_decreased_sensitivity_to | 0.95593183 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.95466114 |
| 72 | MP0000598_abnormal_liver_morphology | 0.95419101 |
| 73 | MP0002272_abnormal_nervous_system | 0.94983920 |
| 74 | MP0003878_abnormal_ear_physiology | 0.94700426 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.94700426 |
| 76 | MP0003186_abnormal_redox_activity | 0.94668502 |
| 77 | MP0005174_abnormal_tail_pigmentation | 0.93577937 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.92872647 |
| 79 | MP0001529_abnormal_vocalization | 0.92396367 |
| 80 | MP0004133_heterotaxia | 0.92146080 |
| 81 | MP0009763_increased_sensitivity_to | 0.90720660 |
| 82 | MP0001346_abnormal_lacrimal_gland | 0.90333441 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.87988695 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 0.87832838 |
| 85 | MP0002102_abnormal_ear_morphology | 0.86452073 |
| 86 | MP0002168_other_aberrant_phenotype | 0.85607052 |
| 87 | MP0002009_preneoplasia | 0.85227286 |
| 88 | MP0009745_abnormal_behavioral_response | 0.85213155 |
| 89 | MP0002557_abnormal_social/conspecific_i | 0.84259678 |
| 90 | MP0001293_anophthalmia | 0.82759292 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.81694617 |
| 92 | MP0010234_abnormal_vibrissa_follicle | 0.80296495 |
| 93 | MP0003633_abnormal_nervous_system | 0.80052320 |
| 94 | MP0005195_abnormal_posterior_eye | 0.80023059 |
| 95 | MP0003787_abnormal_imprinting | 0.79184576 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 0.78931181 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.78041328 |
| 98 | MP0000604_amyloidosis | 0.78017639 |
| 99 | MP0001963_abnormal_hearing_physiology | 0.77641988 |
| 100 | MP0002233_abnormal_nose_morphology | 0.77276862 |
| 101 | MP0005389_reproductive_system_phenotype | 0.76934240 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.76775012 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.76633322 |
| 104 | MP0008469_abnormal_protein_level | 0.76575712 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 0.76545353 |
| 106 | MP0004142_abnormal_muscle_tone | 0.76522145 |
| 107 | MP0002132_abnormal_respiratory_system | 0.76240729 |
| 108 | MP0003718_maternal_effect | 0.75713898 |
| 109 | MP0004924_abnormal_behavior | 0.72705288 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.72705288 |
| 111 | MP0005408_hypopigmentation | 0.71342439 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.70466624 |
| 113 | MP0002971_abnormal_brown_adipose | 0.69913236 |
| 114 | MP0003705_abnormal_hypodermis_morpholog | 0.66569805 |
| 115 | MP0002796_impaired_skin_barrier | 0.66022931 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.65648190 |
| 117 | MP0005187_abnormal_penis_morphology | 0.62309045 |
| 118 | MP0008789_abnormal_olfactory_epithelium | 0.60574351 |
| 119 | MP0005334_abnormal_fat_pad | 0.59283050 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.58841170 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.57532001 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.57138882 |
| 123 | MP0005448_abnormal_energy_balance | 0.56441905 |
| 124 | MP0002060_abnormal_skin_morphology | 0.55331563 |
| 125 | MP0002098_abnormal_vibrissa_morphology | 0.53604836 |
| 126 | MP0005535_abnormal_body_temperature | 0.52778198 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.52747085 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.51401066 |
| 129 | MP0004130_abnormal_muscle_cell | 0.51118331 |
| 130 | MP0001944_abnormal_pancreas_morphology | 0.51117357 |
| 131 | MP0005670_abnormal_white_adipose | 0.50465225 |
| 132 | MP0003698_abnormal_male_reproductive | 0.48479987 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.48415026 |
| 134 | MP0001661_extended_life_span | 0.48335649 |
| 135 | MP0002693_abnormal_pancreas_physiology | 0.46533491 |
| 136 | MP0005395_other_phenotype | 0.45703921 |
| 137 | MP0001929_abnormal_gametogenesis | 0.44915098 |
| 138 | MP0003953_abnormal_hormone_level | 0.44782976 |
| 139 | MP0005499_abnormal_olfactory_system | 0.44114283 |
| 140 | MP0005394_taste/olfaction_phenotype | 0.44114283 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.43889970 |
| 142 | MP0000427_abnormal_hair_cycle | 0.42746279 |
| 143 | MP0006082_CNS_inflammation | 0.42481880 |
| 144 | MP0000639_abnormal_adrenal_gland | 0.41938724 |
| 145 | MP0003329_amyloid_beta_deposits | 0.40315523 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.40291062 |
| 147 | MP0008874_decreased_physiological_sensi | 0.39546953 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.39472179 |
| 149 | MP0002160_abnormal_reproductive_system | 0.38734871 |
| 150 | MP0000579_abnormal_nail_morphology | 0.38727280 |
| 151 | MP0002822_catalepsy | 0.38621114 |
| 152 | MP0009053_abnormal_anal_canal | 0.38266242 |
| 153 | MP0000538_abnormal_urinary_bladder | 0.37213906 |
| 154 | MP0005266_abnormal_metabolism | 0.37116894 |
| 155 | MP0000566_synostosis | 0.37088270 |
| 156 | MP0001756_abnormal_urination | 0.36765206 |
| 157 | MP0005464_abnormal_platelet_physiology | 0.35939642 |
| 158 | MP0009384_cardiac_valve_regurgitation | 0.35291271 |
| 159 | MP0002161_abnormal_fertility/fecundity | 0.35170019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.74250404 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.67314903 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.60471840 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.15223386 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.04127605 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.02198489 |
| 7 | Xanthomatosis (HP:0000991) | 5.63226849 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.81671370 |
| 9 | Complement deficiency (HP:0004431) | 4.68500497 |
| 10 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.66492121 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.50815396 |
| 12 | Joint hemorrhage (HP:0005261) | 4.43523160 |
| 13 | True hermaphroditism (HP:0010459) | 4.27797465 |
| 14 | Hyperglycinemia (HP:0002154) | 4.23124738 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.21091344 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 4.15079071 |
| 17 | Pancreatic fibrosis (HP:0100732) | 4.14660386 |
| 18 | Epidermoid cyst (HP:0200040) | 4.14078793 |
| 19 | Pancreatic cysts (HP:0001737) | 4.12317030 |
| 20 | Ketosis (HP:0001946) | 4.11172605 |
| 21 | Fat malabsorption (HP:0002630) | 4.06381984 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.99537009 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.89297242 |
| 24 | Hyperammonemia (HP:0001987) | 3.85470653 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70506487 |
| 26 | Hyperglycinuria (HP:0003108) | 3.64203881 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.63384350 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61379295 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.58354333 |
| 30 | Bronchiectasis (HP:0002110) | 3.55191934 |
| 31 | Hyperactive renin-angiotensin system (HP:0000841) | 3.49969999 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.47724781 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.47724781 |
| 34 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.37555524 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.33431120 |
| 36 | Abnormality of complement system (HP:0005339) | 3.32259723 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.29953098 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 3.27298951 |
| 39 | Cystic liver disease (HP:0006706) | 3.20356403 |
| 40 | Chronic bronchitis (HP:0004469) | 3.10014202 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.07491912 |
| 42 | Ketoacidosis (HP:0001993) | 3.06070200 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04604370 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.03349230 |
| 45 | Nephronophthisis (HP:0000090) | 3.02089110 |
| 46 | Metabolic alkalosis (HP:0200114) | 3.00048582 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.97520288 |
| 48 | Occipital encephalocele (HP:0002085) | 2.97205996 |
| 49 | Steatorrhea (HP:0002570) | 2.93398422 |
| 50 | Abnormality of chloride homeostasis (HP:0011422) | 2.89342716 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.88804885 |
| 52 | Abnormality of the renal cortex (HP:0011035) | 2.86621925 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.86053470 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.82467635 |
| 55 | Rhinitis (HP:0012384) | 2.81439185 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.81175030 |
| 57 | Hyperventilation (HP:0002883) | 2.81077984 |
| 58 | Spontaneous abortion (HP:0005268) | 2.80933950 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.79230801 |
| 60 | Poikilocytosis (HP:0004447) | 2.79085687 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.78960215 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78827979 |
| 63 | Amyloidosis (HP:0011034) | 2.75440170 |
| 64 | Vascular calcification (HP:0004934) | 2.74530518 |
| 65 | Abnormality of proline metabolism (HP:0010907) | 2.68180618 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.68180618 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.66765708 |
| 68 | Malnutrition (HP:0004395) | 2.66432458 |
| 69 | Delayed CNS myelination (HP:0002188) | 2.62150591 |
| 70 | Acanthocytosis (HP:0001927) | 2.59291222 |
| 71 | Hyperaldosteronism (HP:0000859) | 2.57960183 |
| 72 | Gait imbalance (HP:0002141) | 2.57535974 |
| 73 | Myocardial infarction (HP:0001658) | 2.56408530 |
| 74 | Chronic hepatic failure (HP:0100626) | 2.56375357 |
| 75 | Congenital primary aphakia (HP:0007707) | 2.52799890 |
| 76 | Glycosuria (HP:0003076) | 2.51232093 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 2.51232093 |
| 78 | Metabolic acidosis (HP:0001942) | 2.50607150 |
| 79 | Abnormality of serum amino acid levels (HP:0003112) | 2.49881439 |
| 80 | Abnormal ciliary motility (HP:0012262) | 2.49134028 |
| 81 | Furrowed tongue (HP:0000221) | 2.46498785 |
| 82 | Alkalosis (HP:0001948) | 2.45562210 |
| 83 | Hypoglycemic seizures (HP:0002173) | 2.44006733 |
| 84 | Congenital hepatic fibrosis (HP:0002612) | 2.42446400 |
| 85 | Postaxial foot polydactyly (HP:0001830) | 2.41425272 |
| 86 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.39246828 |
| 87 | Decreased central vision (HP:0007663) | 2.37995412 |
| 88 | Cardiovascular calcification (HP:0011915) | 2.37376811 |
| 89 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.36713817 |
| 90 | Absent/shortened dynein arms (HP:0200106) | 2.36713817 |
| 91 | Chronic sinusitis (HP:0011109) | 2.36573533 |
| 92 | Hypokalemic alkalosis (HP:0001949) | 2.36118338 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.33301319 |
| 94 | Nephrogenic diabetes insipidus (HP:0009806) | 2.32904117 |
| 95 | Increased circulating renin level (HP:0000848) | 2.32793478 |
| 96 | Abnormal biliary tract physiology (HP:0012439) | 2.29334705 |
| 97 | Bile duct proliferation (HP:0001408) | 2.29334705 |
| 98 | Gout (HP:0001997) | 2.26354960 |
| 99 | Late onset (HP:0003584) | 2.24789083 |
| 100 | Pancreatitis (HP:0001733) | 2.24534966 |
| 101 | Cholecystitis (HP:0001082) | 2.22799936 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 2.22799936 |
| 103 | Tubulointerstitial nephritis (HP:0001970) | 2.21776117 |
| 104 | Tubular atrophy (HP:0000092) | 2.21157153 |
| 105 | Confusion (HP:0001289) | 2.21096789 |
| 106 | Neonatal onset (HP:0003623) | 2.20714129 |
| 107 | Abnormality of macular pigmentation (HP:0008002) | 2.20469193 |
| 108 | Enlarged kidneys (HP:0000105) | 2.20272599 |
| 109 | Male pseudohermaphroditism (HP:0000037) | 2.17396670 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16929778 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.16929778 |
| 112 | Cerebral edema (HP:0002181) | 2.16868944 |
| 113 | Abnormal drinking behavior (HP:0030082) | 2.16385443 |
| 114 | Polydipsia (HP:0001959) | 2.16385443 |
| 115 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.16364424 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.16364424 |
| 117 | Renal salt wasting (HP:0000127) | 2.14239176 |
| 118 | Large for gestational age (HP:0001520) | 2.11584488 |
| 119 | Skin nodule (HP:0200036) | 2.11356504 |
| 120 | Lethargy (HP:0001254) | 2.11254416 |
| 121 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.10866648 |
| 122 | Renal cortical cysts (HP:0000803) | 2.09147090 |
| 123 | Sclerocornea (HP:0000647) | 2.09070115 |
| 124 | Nasal polyposis (HP:0100582) | 2.08269000 |
| 125 | Abnormality of vitamin B metabolism (HP:0004340) | 2.08010443 |
| 126 | Irritability (HP:0000737) | 2.05605626 |
| 127 | Genital tract atresia (HP:0001827) | 2.05598550 |
| 128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05305844 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 2.04872164 |
| 130 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04846709 |
| 131 | Systemic lupus erythematosus (HP:0002725) | 2.04458411 |
| 132 | Abnormal urine output (HP:0012590) | 2.01053636 |
| 133 | Infertility (HP:0000789) | 2.00793895 |
| 134 | Polyuria (HP:0000103) | 2.00369718 |
| 135 | Abnormality of renal excretion (HP:0011036) | 1.99819474 |
| 136 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96792197 |
| 137 | Chronic otitis media (HP:0000389) | 1.95671719 |
| 138 | Chorioretinal atrophy (HP:0000533) | 1.95379738 |
| 139 | Proximal tubulopathy (HP:0000114) | 1.94253743 |
| 140 | Vaginal atresia (HP:0000148) | 1.94152464 |
| 141 | Abnormal gallbladder morphology (HP:0012437) | 1.93979563 |
| 142 | Bronchitis (HP:0012387) | 1.93938331 |
| 143 | Sensorimotor neuropathy (HP:0007141) | 1.93820545 |
| 144 | Generalized aminoaciduria (HP:0002909) | 1.93657278 |
| 145 | Thrombophlebitis (HP:0004418) | 1.93246293 |
| 146 | Alveolar cell carcinoma (HP:0006519) | 1.92289851 |
| 147 | Abnormal biliary tract morphology (HP:0012440) | 1.90302520 |
| 148 | Anencephaly (HP:0002323) | 1.88827855 |
| 149 | Abnormality of the nasal mucosa (HP:0000433) | 1.88762675 |
| 150 | Esophageal varix (HP:0002040) | 1.87640814 |
| 151 | Gingival bleeding (HP:0000225) | 1.86974117 |
| 152 | Hyperglycemia (HP:0003074) | 1.85265497 |
| 153 | Hyperkalemia (HP:0002153) | 1.84790363 |
| 154 | Menorrhagia (HP:0000132) | 1.84138597 |
| 155 | Brushfield spots (HP:0001088) | 1.83666181 |
| 156 | Hypokalemia (HP:0002900) | 1.83528314 |
| 157 | Hypochromic anemia (HP:0001931) | 1.82653424 |
| 158 | Abnormality of midbrain morphology (HP:0002418) | 1.82581037 |
| 159 | Molar tooth sign on MRI (HP:0002419) | 1.82581037 |
| 160 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.81281919 |
| 161 | Vomiting (HP:0002013) | 1.80697068 |
| 162 | Postaxial hand polydactyly (HP:0001162) | 1.80697050 |
| 163 | Mitral stenosis (HP:0001718) | 1.80634684 |
| 164 | Elevated hepatic transaminases (HP:0002910) | 1.80416556 |
| 165 | Abnormality of potassium homeostasis (HP:0011042) | 1.80373602 |
| 166 | Recurrent sinusitis (HP:0011108) | 1.78110998 |
| 167 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76614743 |
| 168 | Dyskinesia (HP:0100660) | 1.76492469 |
| 169 | Median cleft lip (HP:0000161) | 1.75926363 |
| 170 | Hyperphosphaturia (HP:0003109) | 1.73814698 |
| 171 | Potter facies (HP:0002009) | 1.71576311 |
| 172 | Facial shape deformation (HP:0011334) | 1.71576311 |
| 173 | Widely patent fontanelles and sutures (HP:0004492) | 1.69938077 |
| 174 | Male infertility (HP:0003251) | 1.67742488 |
| 175 | Poor coordination (HP:0002370) | 1.65996300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.83336799 |
| 2 | ACVR1B | 4.10527950 |
| 3 | MAPK15 | 3.74508972 |
| 4 | ERN1 | 3.14100488 |
| 5 | TAOK3 | 2.87354220 |
| 6 | SIK1 | 2.69642526 |
| 7 | INSRR | 2.65544201 |
| 8 | FGFR4 | 2.58905045 |
| 9 | PDK4 | 2.58897560 |
| 10 | PDK3 | 2.58897560 |
| 11 | LMTK2 | 2.57147436 |
| 12 | WNK3 | 2.53137371 |
| 13 | MST4 | 2.45034843 |
| 14 | STK39 | 2.25872808 |
| 15 | ERBB4 | 2.25134368 |
| 16 | DAPK2 | 2.25060227 |
| 17 | BMPR1B | 2.18296770 |
| 18 | FRK | 2.18007455 |
| 19 | OXSR1 | 2.12350194 |
| 20 | FLT3 | 2.04476092 |
| 21 | RIPK1 | 1.96434061 |
| 22 | MAP3K3 | 1.91654928 |
| 23 | MAPKAPK3 | 1.88706644 |
| 24 | PIK3CA | 1.85901665 |
| 25 | DYRK1B | 1.84567402 |
| 26 | STK38L | 1.77542671 |
| 27 | CASK | 1.69818149 |
| 28 | BCR | 1.68975660 |
| 29 | TIE1 | 1.62859984 |
| 30 | EEF2K | 1.57682346 |
| 31 | LATS1 | 1.54312625 |
| 32 | CAMK2G | 1.50756057 |
| 33 | MST1R | 1.50433573 |
| 34 | EPHA3 | 1.45700520 |
| 35 | NUAK1 | 1.45575604 |
| 36 | MAPK11 | 1.41115337 |
| 37 | ADRBK2 | 1.39173790 |
| 38 | PDK2 | 1.38234596 |
| 39 | MAPK13 | 1.36416715 |
| 40 | BRSK2 | 1.33911251 |
| 41 | PIK3CG | 1.33759278 |
| 42 | PTK6 | 1.33169492 |
| 43 | EPHB2 | 1.32000508 |
| 44 | MAP4K2 | 1.28629812 |
| 45 | EPHA4 | 1.27871609 |
| 46 | PRKAA2 | 1.25407348 |
| 47 | WNK4 | 1.23206071 |
| 48 | TNIK | 1.22379873 |
| 49 | MAP2K4 | 1.19868601 |
| 50 | AKT3 | 1.18946177 |
| 51 | MAP3K2 | 1.17502833 |
| 52 | TRIB3 | 1.16332248 |
| 53 | PAK3 | 1.14731857 |
| 54 | EPHA2 | 1.12534257 |
| 55 | PRKG2 | 1.11855786 |
| 56 | PHKG2 | 1.11759852 |
| 57 | PHKG1 | 1.11759852 |
| 58 | NTRK3 | 1.11025930 |
| 59 | PRKCE | 1.10791673 |
| 60 | CDK6 | 1.08988771 |
| 61 | PKN2 | 1.08793972 |
| 62 | TYK2 | 1.08249894 |
| 63 | MAP3K7 | 1.07220373 |
| 64 | TBK1 | 1.00622485 |
| 65 | TGFBR1 | 0.98023001 |
| 66 | CAMK2D | 0.97690514 |
| 67 | BRD4 | 0.97663114 |
| 68 | MAPKAPK5 | 0.94243515 |
| 69 | ICK | 0.93680262 |
| 70 | NEK6 | 0.93277111 |
| 71 | MET | 0.89939637 |
| 72 | MUSK | 0.89375539 |
| 73 | GRK6 | 0.88837588 |
| 74 | CSNK1G1 | 0.88263123 |
| 75 | BRAF | 0.88090440 |
| 76 | YES1 | 0.86601301 |
| 77 | TEC | 0.84111280 |
| 78 | NTRK2 | 0.83978420 |
| 79 | PRKAA1 | 0.82659840 |
| 80 | PTK2B | 0.82220847 |
| 81 | CSNK1A1L | 0.81994055 |
| 82 | CDK4 | 0.80713640 |
| 83 | MAP3K4 | 0.78089334 |
| 84 | IRAK1 | 0.76228026 |
| 85 | MAP3K14 | 0.76012772 |
| 86 | CAMKK2 | 0.73438204 |
| 87 | ADRBK1 | 0.73179680 |
| 88 | JAK2 | 0.73087266 |
| 89 | CSNK1G2 | 0.72423858 |
| 90 | RPS6KB1 | 0.72003027 |
| 91 | DYRK3 | 0.70853969 |
| 92 | CDK9 | 0.70086492 |
| 93 | PASK | 0.69998479 |
| 94 | JAK1 | 0.67729605 |
| 95 | NLK | 0.67264109 |
| 96 | MAP3K10 | 0.67036330 |
| 97 | STK11 | 0.65712473 |
| 98 | CSNK1G3 | 0.65545600 |
| 99 | TXK | 0.63826440 |
| 100 | MAP2K2 | 0.62875413 |
| 101 | SGK223 | 0.61902128 |
| 102 | SGK494 | 0.61902128 |
| 103 | NEK9 | 0.61744376 |
| 104 | PINK1 | 0.60856824 |
| 105 | FER | 0.59698279 |
| 106 | PKN1 | 0.58683308 |
| 107 | MARK1 | 0.58681674 |
| 108 | GSK3A | 0.58472909 |
| 109 | CAMK2B | 0.58436671 |
| 110 | IKBKE | 0.58434981 |
| 111 | PNCK | 0.58359912 |
| 112 | HIPK2 | 0.58076476 |
| 113 | MAPK4 | 0.54953349 |
| 114 | MAP3K12 | 0.54512582 |
| 115 | BMPR2 | 0.54001539 |
| 116 | PRKACG | 0.53682837 |
| 117 | MKNK2 | 0.53225063 |
| 118 | PRKCZ | 0.53036949 |
| 119 | PRKCG | 0.52988470 |
| 120 | PRKACA | 0.52951483 |
| 121 | FGFR2 | 0.52881035 |
| 122 | ERBB3 | 0.52776808 |
| 123 | ERBB2 | 0.51817130 |
| 124 | PRKCA | 0.51346306 |
| 125 | WEE1 | 0.49938145 |
| 126 | ARAF | 0.49576609 |
| 127 | STK38 | 0.48541544 |
| 128 | GRK1 | 0.46215166 |
| 129 | PLK2 | 0.45713463 |
| 130 | STK3 | 0.45017639 |
| 131 | TLK1 | 0.43560820 |
| 132 | PRKCQ | 0.42750532 |
| 133 | SGK3 | 0.42329059 |
| 134 | STK24 | 0.42251526 |
| 135 | PRKG1 | 0.40504417 |
| 136 | EPHB1 | 0.40362761 |
| 137 | ROCK1 | 0.39691938 |
| 138 | TESK1 | 0.38977227 |
| 139 | IGF1R | 0.38372099 |
| 140 | FGFR1 | 0.37666197 |
| 141 | ITK | 0.36116909 |
| 142 | ABL2 | 0.36019403 |
| 143 | MAP2K3 | 0.35863625 |
| 144 | PRKD3 | 0.35340391 |
| 145 | CAMK2A | 0.35079462 |
| 146 | TNK2 | 0.34759828 |
| 147 | SGK2 | 0.34455984 |
| 148 | FGFR3 | 0.34364325 |
| 149 | SGK1 | 0.33595044 |
| 150 | MAP2K6 | 0.33267451 |
| 151 | ABL1 | 0.32948902 |
| 152 | TAOK1 | 0.32742537 |
| 153 | BTK | 0.32458759 |
| 154 | PDGFRB | 0.32165005 |
| 155 | DYRK1A | 0.32027729 |
| 156 | MAPK7 | 0.31747767 |
| 157 | CDK19 | 0.31681351 |
| 158 | MAP3K6 | 0.31413163 |
| 159 | CSK | 0.31176390 |
| 160 | CSNK1A1 | 0.31175278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39819072 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31498677 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13230535 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82168804 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.70019318 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61650466 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60326186 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49034501 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39835168 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37062417 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34946174 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.29405586 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29213120 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.28528718 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14654560 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10920490 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.07112671 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.05821829 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05125084 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99745167 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.92880156 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91219751 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89005301 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88839212 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85602391 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.79839612 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78640443 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.75198477 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.73418571 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72377496 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66962162 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65787486 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65517096 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.58360768 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57712824 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.53629077 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50522350 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47346499 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40113320 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39937122 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35432527 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32938396 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32338711 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30424550 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23274789 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21689822 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.16986865 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16558219 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.10880422 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10568461 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07542100 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06206667 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01217207 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95900965 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95020104 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93255226 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88710801 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88382014 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88320318 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87870769 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87688003 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87375399 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86820970 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86594198 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80882232 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78496138 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76269267 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76212879 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75863725 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68864950 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64163201 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63129767 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62558617 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62273038 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60797129 |
| 76 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59696774 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59100229 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.58633121 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56378960 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51082098 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50327575 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50122200 |
| 83 | Protein export_Homo sapiens_hsa03060 | 0.47458853 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47201769 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46657127 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46170415 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45638163 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43345622 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41683292 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36021068 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33208157 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31990433 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31007948 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.29398597 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.29270743 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.28358478 |
| 97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28126785 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28091476 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28080103 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.27166341 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26521512 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.25685013 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.25673490 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.24272416 |
| 105 | Long-term depression_Homo sapiens_hsa04730 | 0.22471344 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.20402090 |
| 107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20082477 |
| 108 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.19878430 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.17459431 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14005871 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09911513 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.09442697 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08136916 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.08103523 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.06803940 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.03515505 |
| 117 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.01244436 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | -0.1563411 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1258844 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1234598 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | -0.1110374 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1067109 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1041996 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0927884 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0803363 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0615063 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | -0.0397159 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0372404 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0355254 |
| 130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0351361 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0105100 |

